Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
出版年份 2021 全文链接
标题
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
作者
关键词
-
出版物
Viruses-Basel
Volume 13, Issue 8, Pages 1665
出版商
MDPI AG
发表日期
2021-08-24
DOI
10.3390/v13081665
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
- (2020) De Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
- (2020) Naveen Vankadari INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
- (2020) Chunguang Yang et al. Frontiers in Public Health
- Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission—A Preliminary Report of a Retrospective Cohort Study
- (2020) Jin-nong Zhang et al. Current Medical Science
- COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19
- (2020) Ren Kong et al. BIOINFORMATICS
- Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
- (2020) Mathieu Gendrot et al. Travel Medicine and Infectious Disease
- Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
- (2020) Marzieh Nojomi et al. BMC INFECTIOUS DISEASES
- The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
- (2019) Qiuling Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Human Coronaviruses and other Respiratory Infections in Young Adults on a University Campus: Prevalence, Symptoms, and Shedding
- (2018) Brian M. Davis et al. Influenza and Other Respiratory Viruses
- Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
- (2018) Jan Haviernik et al. Viruses-Basel
- The Antiviral Drug Arbidol Inhibits Zika Virus
- (2018) Susan L. Fink et al. Scientific Reports
- Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study
- (2018) Irina A. Leneva et al. JOURNAL OF MEDICAL VIROLOGY
- Molecular Evolution of Human Coronavirus Genomes
- (2017) Diego Forni et al. TRENDS IN MICROBIOLOGY
- Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010–2011 influenza season in Russia
- (2016) I.A. Leneva et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
- (2016) Eve-Isabelle Pécheur et al. JOURNAL OF VIROLOGY
- Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
- (2016) Rameshwar U. Kadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Middle East respiratory syndrome
- (2015) Alimuddin Zumla et al. LANCET
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Thinking Outside the Triangle: Replication Fidelity of the Largest RNA Viruses
- (2014) Everett Clinton Smith et al. Annual Review of Virology
- Pharmacokinetics of single and multiple oral doses of arbidol in healthy Chinese volunteers
- (2013) Yaxin Sun et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Coronavirus Diversity, Phylogeny and Interspecies Jumping
- (2009) Patrick C. Y. Woo et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol
- (2008) Irina A. Leneva et al. ANTIVIRAL RESEARCH
- Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
- (2008) Y. Boriskin et al. CURRENT MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now